Modified Thayer Martin Agar: Composition, Preparation, and Uses

Modified Thayer-Martin (MTM) agar is a selective growth medium designed to isolate pathogenic Neisseria species, particularly the bacteria responsible for gonorrhea and meningococcal disease, from clinical specimens teeming with other microorganisms. It builds on the original Thayer-Martin formulation by adding a fourth antibiotic, trimethoprim, to suppress swarming Proteus species that were contaminating cultures. The medium remains a workhorse in sexually transmitted disease clinics and meningitis surveillance programs worldwide, even as molecular diagnostics have taken over much of routine screening.

What the Base Medium Provides

At its foundation, MTM agar is a rich, nutritionally complex medium built to satisfy the notoriously fussy growth requirements of Neisseria gonorrhoeae and Neisseria meningitidis. The base is GC agar (sometimes labeled GC II), which supplies casein and meat peptones as nitrogen sources, a phosphate buffer to keep the pH stable, and corn starch. The corn starch serves a specific purpose: it neutralizes toxic fatty acids that can accumulate in the agar and kill gonococci before they have a chance to form colonies.¹

On top of the base, two critical supplements are added. Hemoglobin supplies hemin (also called X factor), an iron-containing compound that pathogenic Neisseria cannot synthesize on their own. IsoVitaleX enrichment provides V factor (nicotinamide adenine dinucleotide), along with vitamins, amino acids, coenzymes, ferric ions, and dextrose. Together, these supplements essentially recreate the nutritional environment that pathogenic Neisseria encounter in human mucous membranes, giving the organisms what they need to grow while the antibiotic cocktail deals with everything else.¹

The Antibiotic Cocktail That Makes It Selective

The defining feature of any Thayer-Martin formulation is the combination of antimicrobial agents mixed into the agar. These antibiotics do not target gonococci or meningococci. Instead, they wipe out the normal flora that would otherwise overgrow clinical specimens, especially swabs from the throat, cervix, or rectum where dozens of bacterial and fungal species compete for space. The original Thayer-Martin medium used three agents known as the VCN inhibitor: vancomycin, colistin, and nystatin.²

Each component targets a different class of contaminant:

Vancomycin: Kills gram-positive bacteria such as staphylococci, streptococci, and other common skin and mucosal flora that would otherwise blanket the plate.
Colistin: A polymyxin antibiotic that targets gram-negative organisms other than Neisseria, including many enteric bacteria that show up in rectal and cervical specimens.
Nystatin: An antifungal agent aimed at yeasts, particularly Candida species, which are common inhabitants of mucosal sites.

The “modified” part of MTM comes from the addition of a fourth agent, trimethoprim, creating what is sometimes called the VCNT inhibitor. This addition addressed a persistent problem in clinical laboratories: Proteus species, which are gram-negative bacteria capable of swarming across an agar surface and engulfing gonococcal colonies before they can be identified.

Why Trimethoprim Was the Key Modification

The original three-antibiotic Thayer-Martin medium worked well in many clinical settings, but laboratories dealing with rectal and cervical specimens kept running into contamination from swarming Proteus. These organisms spread across plates in waves, making it impossible to pick out discrete Neisseria colonies. Colistin, the gram-negative-targeting agent in the original mix, was not reliably killing Proteus.

Early work showed that adding trimethoprim to the culture medium completely prevented Proteus swarming without interfering with gonococcal growth. In a series of routine cultures where swarming Proteus overgrew the plates in 21 instances, medium containing trimethoprim blocked swarming in every case while gonococci grew unimpaired.³ A follow-up test on 100 additional specimens that had shown Proteus contamination on standard medium found that trimethoprim-containing plates allowed swarming only once, and not until the second day of incubation.³

A comparative study confirmed the practical payoff: modified Thayer-Martin medium with trimethoprim detected about 10% more gonorrhea-positive female patients than the original Thayer-Martin formulation, largely because fewer plates were lost to contamination.⁴ That gain was clinically meaningful, since missed diagnoses of gonorrhea in women can lead to pelvic inflammatory disease and infertility.

Preparing the Medium in Practice

Making MTM agar involves preparing several components separately and combining them aseptically. The GC agar base is dissolved in about 730 mL of distilled water, brought to a boil, and then autoclaved at 121°C for 15 minutes. Separately, hemoglobin is suspended in 250 mL of distilled water and also autoclaved. Both solutions are then cooled to roughly 45–50°C, which is warm enough to keep the agar liquid but cool enough that the heat-sensitive supplements and antibiotics will not be destroyed.⁵

The IsoVitaleX enrichment and the VCNT antibiotic solution are each prepared in 10 mL volumes and filter-sterilized rather than autoclaved, because the vitamins, coenzymes, and antibiotics would break down at autoclave temperatures. Once all four components have reached the right temperature, the hemoglobin solution, IsoVitaleX, and VCNT solution are aseptically added to the GC agar base, mixed thoroughly, and poured into sterile Petri dishes or distributed into tubes.⁵

Timing matters during preparation. If the base agar cools too much, it solidifies before the supplements can be mixed in. If the supplements are added while the agar is still too hot, the antibiotics and vitamins degrade and the medium loses both its selectivity and its ability to support gonococcal growth. The 45–50°C window is narrow enough that experienced technicians keep a thermometer handy.

Primary Clinical Uses

The medium’s main job is isolating Neisseria gonorrhoeae from body sites where the organism lives alongside dense normal flora. In sexually transmitted disease clinics, specimens from the cervix, urethra, rectum, and pharynx are swabbed and inoculated directly onto MTM plates. In one large comparison study, N. gonorrhoeae was recovered from about 29% of genital cultures and 29% of rectal cultures collected at an STD clinic, while pharyngeal cultures yielded gonococci in roughly 3% of patients.⁶ The low pharyngeal yield reflects how hard it is to grow gonococci from throat specimens even on optimized media, not necessarily a low infection rate.

MTM also plays an important role in meningococcal surveillance. Public health programs tracking the carriage rate of Neisseria meningitidis in populations use nasopharyngeal or oropharyngeal swabs plated on MTM to determine how many people carry the bacterium without symptoms.⁷ Studies in military recruits and schoolchildren have used modified Thayer-Martin plates inoculated directly from pharyngeal swabs and incubated in a carbon dioxide-enriched atmosphere to screen for meningococcal carriers.⁸⁹ These carriage surveys inform vaccination campaigns and outbreak responses.

Incubation Conditions and Colony Appearance

Pathogenic Neisseria are capnophilic, meaning they grow best in an atmosphere enriched with carbon dioxide. Inoculated MTM plates are typically placed in a CO₂ incubator set to about 5–10% CO₂ at 35–37°C, or in a candle extinction jar (a sealed container with a burning candle that consumes oxygen and raises CO₂ levels). Plates are usually examined at 24 and 48 hours.

Gonococcal colonies on MTM are small, grayish, and translucent, often with a glistening surface. Colony morphology remains consistent across related formulations of gonococcal media, including those modified with sodium bicarbonate to reduce the need for a specialized CO₂ atmosphere.¹⁰ Suspect colonies are then confirmed using Gram stain (looking for gram-negative diplococci) and oxidase testing, followed by further biochemical or molecular identification.

How MTM Compares to Other Selective Media

Several alternative selective media have been developed over the decades, each tweaking the antimicrobial mix or the nutritional base. The most commonly discussed alternatives are Martin-Lewis agar, New York City (NYC) medium, and GC-Lect agar.

Martin-Lewis agar swaps nystatin for anisomycin (a different antifungal) and adjusts the vancomycin concentration. Modified NYC medium uses a clear, lysed-horse-blood base instead of hemoglobin and supports the growth of genital mycoplasmas in addition to gonococci, making it a dual-purpose medium. In a study of 1,250 clinical specimens, modified NYC medium and Martin-Lewis medium recovered comparable numbers of gonococcal isolates with no statistically significant difference between them.¹¹ A separate comparison found that commercially prepared NYC medium and MTM produced nearly identical gonococcal isolation rates (726 isolates on NYC versus 737 on MTM), though NYC plates showed slightly less contamination.¹²

GC-Lect agar was designed specifically to address some of MTM’s weak spots. It inhibited vancomycin-resistant Staphylococcus epidermidis that could grow on MTM, and it was less likely to suppress vancomycin-susceptible strains of gonococci. Visible gonococcal growth appeared within 24 hours on 72% of positive GC-Lect cultures, compared to only 52% on the reference medium.¹³ GC-Lect also completely blocked Capnocytophaga species from oropharyngeal cultures, organisms that frequently appeared on MTM from some manufacturers and could be confused with Neisseria on initial examination.¹³

Despite these incremental improvements, no single medium has clearly replaced MTM across the board. Each formulation has trade-offs between contamination rates, sensitivity for fastidious gonococcal strains, and cost. Many laboratories use MTM as their default and keep awareness of the alternatives for situations where specific contamination problems arise.

Known Limitations

The most clinically consequential limitation of MTM involves vancomycin-sensitive strains of N. gonorrhoeae. Vancomycin is supposed to target only gram-positive contaminants, but some gonococcal strains are susceptible to it at the concentrations used in the medium. In a study of 119 consecutive gonococcal isolates, 17 strains were sensitive to vancomycin at the standard concentration of 3 micrograms per milliliter. When a vancomycin-containing medium was compared head-to-head with a vancomycin-free medium on 50 consecutive strains, 10 out of 50 failed to grow on the plate with vancomycin.¹⁴ That is a 20% false-negative rate in that sample, meaning one in five infections could be missed if the laboratory relied solely on a vancomycin-containing selective medium.

The prevalence of vancomycin-sensitive gonococci varies by population and geographic region, so the practical impact differs from lab to lab. The standard recommendation is to inoculate both a selective medium like MTM and a non-selective chocolate agar plate when gonorrhea is strongly suspected, so that vancomycin-sensitive strains have a medium on which they can grow freely. The trade-off is that the non-selective plate will show all the contaminants that MTM is designed to suppress, so the technician has more colonies to sort through.

Nystatin, the antifungal component, also has recognized weaknesses. Early testing showed that nystatin in the Thayer-Martin formulation failed to inhibit Candida albicans across a wide range of inoculum sizes.¹⁵ Amphotericin B was shown to be a more effective antifungal substitute, and some formulations (such as Martin-Lewis agar) switched to anisomycin for this reason. Laboratories that experience frequent yeast contamination on MTM plates sometimes switch to a formulation with a different antifungal agent.

MTM in the Age of Molecular Diagnostics

Nucleic acid amplification tests (NAATs) have largely taken over as the front-line screening method for gonorrhea in high-income settings. NAATs are faster, can be run on urine samples instead of swabs, and are more sensitive than culture. So why does MTM still matter?

The answer is antimicrobial resistance surveillance. NAATs detect DNA or RNA; they cannot tell you whether the organism is resistant to the antibiotics used to treat it. Culture on MTM or a similar medium produces live bacteria that can be subjected to susceptibility testing. With gonorrhea becoming increasingly resistant to available antibiotics, public health authorities need a steady supply of cultured isolates to track resistance trends. A study of asymptomatic men who screened positive for gonorrhea by urine NAAT found that culture of urethral swabs successfully isolated viable gonococci in most cases, confirming that positive NAAT results in asymptomatic individuals represent true infections with live organisms that can be cultured and tested for resistance.¹⁶

This means the role of MTM has shifted in many laboratories. Rather than being the primary diagnostic tool, it serves as a confirmatory and surveillance medium. Clinics screen with NAATs and then perform culture on specimens from patients with positive results, treatment failures, or epidemiologically significant cases. The medium’s selectivity is still valuable in this workflow because pharyngeal and rectal swabs, the specimen types most relevant to resistance monitoring, carry the heaviest burden of normal flora.

Specimen-Specific Considerations

Not all body sites behave the same way on MTM. Urethral specimens from men with symptomatic gonorrhea are relatively straightforward: the bacterial load is typically high and competing flora is modest, so both selective and non-selective media perform well. The real value of MTM shows up in specimens from the cervix, rectum, and pharynx, where normal flora is dense and diverse.

Pharyngeal specimens are particularly challenging. The throat harbors nonpathogenic Neisseria species that look similar to gonococci on initial examination, plus a wide variety of gram-positive and gram-negative bacteria. Even on optimized selective media, pharyngeal gonococcal cultures have lower yields than genital cultures, as the STD clinic study mentioned earlier showed with only about 3% of pharyngeal cultures yielding N. gonorrhoeae compared to roughly 29% from genital sites.⁶ Laboratories processing large volumes of pharyngeal specimens sometimes encounter Capnocytophaga and other oral bacteria breaking through the antibiotic barrier, which is one reason alternative formulations like GC-Lect were developed.

Rectal specimens carry their own challenges: the sheer density and diversity of enteric bacteria can overwhelm the colistin and trimethoprim in the medium, especially if the specimen is heavily loaded. Careful swabbing technique (avoiding fecal contamination by inserting the swab past the anal sphincter and sampling the rectal mucosa directly) helps, but some contamination is unavoidable. Meningococcal carriage studies face a similar issue with nasopharyngeal specimens, where the target organism may represent a tiny fraction of the total bacterial population on the swab.

Quality Control and Storage Concerns

MTM plates are more perishable than simpler agar formulations because the antibiotics and enrichment supplements degrade over time. Plates are typically stored at 2–8°C and used within a few weeks of preparation, though exact shelf life depends on the manufacturer’s validation. Laboratories running quality control check each new batch with known positive and negative organisms: a reference strain of N. gonorrhoeae should grow, while organisms like Staphylococcus aureus and Candida albicans should be inhibited.

One practical wrinkle is that not all commercially manufactured MTM plates perform identically. The GC-Lect development study found that Capnocytophaga species were frequently isolated on MTM plates from two of three manufacturers, suggesting variability in antibiotic concentrations or agar composition across commercial sources.¹³ Laboratories that switch suppliers or receive a new lot number sometimes see shifts in contamination rates, and batch-to-batch quality control testing is not optional for reliable results.

1
Microbe Notes. Modified Thayer Martin Agar- Composition, Principle, Preparation, Results, Uses
2
Microbe Notes. Modified Thayer Martin Agar: Composition, Preparation, and Uses
3
Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology. TRIMETHOPRIM FOR THE PREVENTION OF OVERGROWTH BY SWARMING PROTEUS IN THE CULTIVATION OF GONOCOCCI
4
PubMed Central. New system for cultivation of Neisseria gonorrhoeae
5
Microbe Notes. Modified Thayer Martin Agar: Composition, Preparation, and Uses – Section: Preparation of Modified Thayer Martin Agar
6
PubMed Central. Comparison of GC-Lect and modified Thayer-Martin medium for isolation of Neisseria gonorrhoeae
7
PubMed Central. THAYER-MARTIN SELECTIVE MEDIUM FOR THE CULTIVATION OF NEISSERIA MENINGITIDIS FROM THE NASOPHARYNX
8
PubMed Central. Carriage rates of Neisseria meningitidis serogroups: determination among freshmen conscripts before vaccination
9
PubMed Central. Carriage rate of Neisseria meningitidis, antibiotic susceptibility pattern and associated risk factors among primary school children in Gondar town, Northwest Ethiopia
10
PubMed Central. Improved Neisseria gonorrhoeae culture media without atmospheric CO 2
11
PubMed Central. Comparison of modified New York City medium with Martin-Lewis Medium for recovery of Neisseria gonorrhoeae from clinical specimens
12
PubMed Central. Comparative evaluation of New York City and modified Thayer-Martin media for isolation of Neisseria gonorrhoeae
13
PubMed Central. New selective medium for the isolation of Neisseria gonorrhoeae
14
PubMed Central. Vancomycin-sensitive strains of Neisseria gonorrhoeae. A problem for the diagnostic laboratory
15
PubMed Central. Superiority of amphotericin over nystatin in Thayer-Martin medium
16
PubMed. Culture obtained from urethral swab of asymptomatic men who screen positive for Neisseria gonorrhoeae by urine nucleic acid amplification testing